The Illinois-based company recommended its shareholders vote against the deal because changes in US tax law made the purchase less attractive. Basingstoke-based Shire, best known for its drugs to treat attention deficit disorder, will receive a break fee of 1.6 billion US dollars (£1 billion) once a meeting of AbbVie shareholders is held to rubber-stamp […]